Xeris Pharmaceuticals Inc reported $59.49M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 13.27M 13.06M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
Horizon Pharma HZNP:US $ 1068.55M 256.23M
Jazz Pharmaceuticals JAZZ:US 1000 0
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Perrigo Ordinary Shares PRGO:US $ 2078.1M 1760.6M
Supernus Pharmaceuticals SUPN:US $ 215.28M 8.49M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
Zogenix ZGNX:US $ 106.14M 28.81M